Bank of America
REVB icon

Bank of America’s Revelation Biosciences REVB Stock Holding History

Bank of America’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12
Closed -$38 – 6652
2025
Q4 		$38 Buy
12
+8
+200% +$35 ﹤0.01% 7003
2025
Q3 		$20 Buy
4
+3
+300% +$29 ﹤0.01% 8164
2025
Q2 		$7 Sell
1
-1
-50% -$26 ﹤0.01% 8310
2025
Q1 		$48 Buy
2
+1
+100% +$56 ﹤0.01% 7992
2024
Q4 		$121 Buy
+1
New +$133 ﹤0.01% 7698
2024
Q3 		– Hold
0
– – – 7936
2024
Q2 		– Hold
0
– – – 7964
2021
Q4 		– Sell
-1
Closed -$2.72M – 8565
2021
Q3 		$2.72M Hold
1
– – ﹤0.01% 4148
2021
Q2 		$2.51M Hold
1
– – ﹤0.01% 4137
2021
Q1 		$2.5M Hold
1
– – ﹤0.01% 4061
2020
Q4 		$2.51M Buy
+1
New +$2.02M ﹤0.01% 3744

Other funds holding REVB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

Bank of America's REVB Position: Q1 2026 in Review

Bank of America sold out of Revelation Biosciences (REVB) in Q1 2026, closing a stake of 12 shares — an estimated $38 sold.

Bank of America first reported a position in REVB in Q4 2020 and held it in 9 quarters. The position peaked at $2.72M in Q3 2021. 12 funds tracked by Wall St. Rank hold REVB as of Q1 2026.

  • Bank of America reported no remaining Revelation Biosciences position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 12 Revelation Biosciences shares in Q1 2026, an estimated $38.
  • Bank of America first reported a position in Revelation Biosciences in Q4 2020 and held it in 9 quarters.
  • Bank of America's Revelation Biosciences position peaked at $2.72M in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Revelation Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.